- Home
- CVEO vs FENC Comparison
CVEO vs FENC Comparison
Compare CVEO & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVEO
- FENC
- Stock Information
- Founded
- CVEO 1977
- FENC 1996
- Country
- CVEO United States
- FENC United States
- Employees
- CVEO N/A
- FENC N/A
- Industry
- CVEO Hotels/Resorts
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVEO Consumer Discretionary
- FENC Health Care
- Exchange
- CVEO Nasdaq
- FENC Nasdaq
- Market Cap
- CVEO 281.2M
- FENC 229.8M
- IPO Year
- CVEO N/A
- FENC 2001
- Fundamental
- Price
- CVEO $22.57
- FENC $7.76
- Analyst Decision
- CVEO Strong Buy
- FENC Strong Buy
- Analyst Count
- CVEO 1
- FENC 2
- Target Price
- CVEO $27.00
- FENC $13.00
- AVG Volume (30 Days)
- CVEO 90.4K
- FENC 86.3K
- Earning Date
- CVEO 07-29-2025
- FENC 08-12-2025
- Dividend Yield
- CVEO 4.41%
- FENC N/A
- EPS Growth
- CVEO N/A
- FENC N/A
- EPS
- CVEO N/A
- FENC N/A
- Revenue
- CVEO $660,046,000.00
- FENC $30,912,000.00
- Revenue This Year
- CVEO N/A
- FENC $0.85
- Revenue Next Year
- CVEO $4.45
- FENC $55.16
- P/E Ratio
- CVEO N/A
- FENC N/A
- Revenue Growth
- CVEO N/A
- FENC N/A
- 52 Week Low
- CVEO $18.01
- FENC $3.96
- 52 Week High
- CVEO $28.92
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- CVEO 59.44
- FENC 51.69
- Support Level
- CVEO $22.12
- FENC $7.53
- Resistance Level
- CVEO $22.74
- FENC $8.19
- Average True Range (ATR)
- CVEO 0.57
- FENC 0.47
- MACD
- CVEO -0.03
- FENC -0.12
- Stochastic Oscillator
- CVEO 50.22
- FENC 19.67
About CVEO Civeo Corporation (Canada)
Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.